Skip to content

Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01388283
Enrollment
129
Registered
2011-07-06
Start date
1999-01-31
Completion date
2011-06-30
Last updated
2011-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Keywords

prognostic marker

Brief summary

The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.

Interventions

None listed

Sponsors

Oslo University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 43 Years
Healthy volunteers
Yes

Inclusion criteria

* caucasian, * nulliparous

Exclusion criteria

* preexisting cardiovascular diseases, * diabetes, * hypertension, * inflammatory bowel diseases, * serious organ diseases, and * development of separate gestational diabetes and/or hypertension.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026